Literature DB >> 15127292

The influence of parasitism on the pharmacokinetics of moxidectin in lambs.

Anne Lespine1, Jean-François Sutra, Jacques Dupuy, Michel Alvinerie, Gilles Aumont.   

Abstract

Most pharmacokinetic studies on anthelmintic drugs have been performed on non-parasitized animals. However, it seems likely that the parasite burden could influence the deposition of such drugs. The pharmacokinetics of moxidectin administered orally and by subcutaneous injection was compared in lambs exposed to nematode infection and in parasite naive lambs. Plasma samples were analyzed for moxidectin over 40 days post-treatment. The main pharmacokinetic parameters calculated demonstrated a significant change in drug deposition in infected lambs when compared to controls. The area under the plasma concentration-time curve was decreased 54% and 46% by infection in the subcutaneous and oral groups, respectively. There was also a major decrease in the mean residence time in parasitized lambs. In parallel, the clearance of the drug was increased by infection. Thus, parasite infection dramatically influences the disposition of moxidectin in lambs. These results may contribute to determining a therapeutic strategy adapted to heavily infested animals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127292     DOI: 10.1007/s00436-004-1084-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  21 in total

1.  Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle.

Authors:  C Lanusse; A Lifschitz; G Virkel; L Alvarez; S Sánchez; J F Sutra; P Galtier; M Alvinerie
Journal:  J Vet Pharmacol Ther       Date:  1997-04       Impact factor: 1.786

2.  How long before resistance makes it impossible to control some field strains of Haemonchus contortus in South Africa with any of the modern anthelmintics?

Authors:  J A van Wyk; F S Malan; J L Randles
Journal:  Vet Parasitol       Date:  1997-06       Impact factor: 2.738

3.  Effect of parasitism with Ostertagia circumcincta on pharmacokinetics of fenbendazole in sheep.

Authors:  S E Marriner; E S Evans; J A Bogan
Journal:  Vet Parasitol       Date:  1985-03       Impact factor: 2.738

4.  Moxidectin in cattle: correlation between plasma and target tissues disposition.

Authors:  A Lifschitz; G Virkel; F Imperiale; J F Sutra; P Galtier; C Lanusse; M Alvinerie
Journal:  J Vet Pharmacol Ther       Date:  1999-08       Impact factor: 1.786

5.  Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection.

Authors:  M Alvinerie; J F Sutra; M Badri; P Galtier
Journal:  J Chromatogr B Biomed Appl       Date:  1995-12-01

6.  Effect of Haemonchus contortus infection on the clearance of antipyrine, sulfobromophthalein, chloramphenicol, and sulfathiazole in lambs.

Authors:  J C Kawalek; R H Fetterer
Journal:  Am J Vet Res       Date:  1990-12       Impact factor: 1.156

7.  Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.

Authors:  H A Benchaoui; Q A McKellar
Journal:  Xenobiotica       Date:  1993-04       Impact factor: 1.908

8.  Comparative kinetic disposition of oxfendazole in sheep and goats before and during infection with Haemonchus contortus and Trichostrongylus colubriformis.

Authors:  D R Hennessy; N C Sangster; J W Steel; G H Collins
Journal:  J Vet Pharmacol Ther       Date:  1993-09       Impact factor: 1.786

9.  Decrease in albendazole sulphonation during experimental fascioliasis in sheep.

Authors:  P Galtier; M Alvinerie; Y Plusquellec; A E Tufenkji; G Houin
Journal:  Xenobiotica       Date:  1991-07       Impact factor: 1.908

10.  Effect of parasitism with Nematodirus battus on the pharmacokinetics of levamisole, ivermectin and netobimin.

Authors:  Q A McKellar; F Jackson; R L Coop; E Jackson; E Scott
Journal:  Vet Parasitol       Date:  1991-07       Impact factor: 2.738

View more
  7 in total

1.  Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics.

Authors:  Mohamad Firas Bassissi; Michel Alvinerie; Pascal Guy Pierre Martin; Bertrand Perret; Anne Lespine
Journal:  Pharm Res       Date:  2006-09-15       Impact factor: 4.200

2.  Patterns of doramectin tissue residue depletion in parasitized vs nonparasitized lambs.

Authors:  Rubén Pérez; Cristina Palma; Maria José Nuñez; Ignacio Cabezas
Journal:  Parasitol Res       Date:  2008-01-16       Impact factor: 2.289

3.  Effectiveness evaluation of several cattle anthelmintics via the fecal egg count reduction test.

Authors:  T A Yazwinski; C A Tucker; J A Hornsby; J G Powell; J L Reynolds; Z B Johnson; W Lindsey; T K Silver
Journal:  Parasitol Res       Date:  2009-02-13       Impact factor: 2.289

4.  Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration.

Authors:  Firas Bassissi; Anne Lespine; Michel Alvinerie
Journal:  Parasitol Res       Date:  2005-12-10       Impact factor: 2.289

Review 5.  Confounding factors affecting faecal egg count reduction as a measure of anthelmintic efficacy.

Authors:  Eric R Morgan; Carlos Lanusse; Laura Rinaldi; Johannes Charlier; Jozef Vercruysse
Journal:  Parasite       Date:  2022-04-07       Impact factor: 3.000

6.  Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin and ivermectin in lambs infected with resistant nematodes: Impact of drug treatments on parasite P-glycoprotein expression.

Authors:  Mercedes Lloberas; Luis Alvarez; Carlos Entrocasso; Guillermo Virkel; Mariana Ballent; Laura Mate; Carlos Lanusse; Adrian Lifschitz
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12-03       Impact factor: 4.077

7.  Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen.

Authors:  Cornelis Smit; Daniela Hofmann; Somphou Sayasone; Jennifer Keiser; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2021-07-23       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.